BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21519024)

  • 1. Mitotic rate and sentinel lymph node tumor burden topography: integration into melanoma staging and stratification use in clinical trials.
    Averbook BJ
    J Clin Oncol; 2011 Jun; 29(16):2137-41. PubMed ID: 21519024
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
    Wilson LL
    Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
    Starz H; Balda BR; Krämer KU; Büchels H; Wang H
    Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
    J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center.
    Meier A; Satzger I; Völker B; Kapp A; Gutzmer R
    Cancer; 2010 Jul; 116(13):3178-88. PubMed ID: 20564647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of sentinel lymph node biopsy for staging melanoma.
    Majumder B
    Br J Surg; 2000 Sep; 87(9):1250-1. PubMed ID: 10973420
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 9. Sentinel lymph-node false positivity in melanoma.
    van Akkooi AC; de Wilt JH; Voit C; Verhoef C; Suciu S; Eggermont AM
    Nat Clin Pract Oncol; 2008 Apr; 5(4):E2. PubMed ID: 18376421
    [No Abstract]   [Full Text] [Related]  

  • 10. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
    Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of melanoma.
    Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
    Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
    [No Abstract]   [Full Text] [Related]  

  • 14. Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
    Roach BA; Burton AL; Mays MP; Ginter BA; Martin RC; Stromberg AJ; Hagendoorn L; McMasters KM; Scoggins CR
    Am J Surg; 2010 Dec; 200(6):759-63; discussion 763-4. PubMed ID: 21146017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in molecular staging of melanoma patients: multimarker analysis of archival lymph node tissue.
    Busam KJ
    J Clin Oncol; 2003 Oct; 21(19):3550-1. PubMed ID: 12913105
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).
    Stitzenberg KB; Groben PA; Stern SL; Thomas NE; Hensing TA; Sansbury LB; Ollila DW
    Ann Surg Oncol; 2004 Oct; 11(10):900-6. PubMed ID: 15383424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
    Roberts AA; Cochran AJ
    J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
    Davids V; Kidson SH; Hanekom GS
    Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sentinel node biopsy in melanoma: an update].
    Botella-Estrada R; Nagore E
    Actas Dermosifiliogr; 2011 Dec; 102(10):749-53. PubMed ID: 21640960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.